chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Losing extreme amounts of hair. Brushing hair and just running hands through hair results in too much loss.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Aug2021 16:30 (Lot number: FC3184) at the age of 67 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3181, Location of injection: Arm Right, Vaccine Administration Time: 04:30 PM), administration date: 08Aug2021, when the patient was 67 years old, for Covid-19 immunization. The following information was reported: ALOPECIA (non-serious) with onset 15Sep2021 09:00, outcome "not recovered", described as "Losing extreme amounts of hair. Brushing hair and just running hands through hair results in too much loss.". Therapeutic measures were not taken as a result of alopecia.  Additional information: Age group was Elderly (65+ Years), Other vaccine same date vaccine date was 29Aug2021.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, patient had not tested for COVID-19. no allergies was reported. no other medical history reported.  No follow-up attempts are possible. No further information is expected.
brain fog x 2 days, muscle ache x 5 days, soreness to touch x 7 days
Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: Rash that was peeling and hives
A 25 year old female pt who was vaccinated with a first and second dose of varicella  virus vaccine live in January and February of 1999. It was known the pt was definitely pregnant when receiving the second dose. This report is part of the pregnancy registry. Follow Up information reported the pt never returned to the Dr's office after her initial visit and the Dr had no information about the outcome of the pt pregnancy. Follow up information from the Dr's office indicated the on 04-OCT-1999, the pt delivered via C-section and the baby was breech. The pt was also noted that during her pregnancy had several ultrasounds which revealed a short cervix. She also had an amniocentesis done which was normal. The pt was taking prenatal vitamins. The pt had a scheduled C-section because of the breech presentation. The pt gave birth tom a healthy 8 lb 2 oz male infant. Physical exam of the infant showed mild respiratory distress requiring suctioning and oxygen. Occasional rales were heard. On 04-OCT-1999, the infant's Coomb's test was negative. On 05-OCT-1999 the infant was feeding poorly from the breast. On 05-OCT-1999, the hemoglobin screen was abnormal with infant having sickle cell trait. The infant had several bilirubin tests and it was noted that the infant's appetite improved with bottle supplementation. On 09-OCT-1999 the infant was discharged to his mother, his lungs clear, perfusion was good and the mild jaundice had significantly improved. Family testing and genetic counseling was suggested for the child's parents regarding sickle cell trait.
I have a bruise at the injection site; When I got the shot, I bled a bit, too.; This is a spontaneous report received from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 21Mar2021 at 11:15 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021, when the patient got the shot, she had bled a bit (vaccination site bleeding) and on 23Mar2021, reportedly two days after the vaccine, the patient had a bruise at the injection site (vaccination site bruising). The patient enquired whether it was normal to have bruise at injection site and was also concerned of vaccine shot bleeding that the vaccine  was not administered correctly in the muscle. The patient had not received any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vaccination site bleeding was recovered while that of vaccination site bruising was not recovered at the time of this report.   Information about lot number has been requested.
Completed series of 5 injections, and HRIG. Within hours developed painful shoulder then knees, arms, legs, feet. Slight amelioration with NSAIDS.
heart palpitations; This is a spontaneous report from a contactable pharmacist reported on behalf of female nurse. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced heart palpitations. While caller is reporting on her experience with the Pfizer COVID 19 vaccine, she says one of the nurses in the hospital said she had heart palpitations after it, she doesn't know if she can give out anything, they may want to contact them but those people may not want to get involved they just said that in conversation and she just thought it was strange that 3 people had the same problem, well one just said she had palpitations. She is not able to go through a report about those people, she does not even know which vaccine she is assuming it was Moderna or Pfizer, but she does not know she was just saying in general. She knew they would probably just call it hear say because she did not have the whole list of stuff. She does not know any information about the people, nor does she have and NDC lot expiration for the COVID 19 vaccine they received, she is not able to go through a report about their experience. The seriousness of the event was reported as non-serious. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021345867 same reporter/drug, different patient and event
Hospitalization: 9/18/2022 - 9/21/2022 Presentation to the ED: SOB.  COVID-19 + date: 9/18/22. Treatment: dexamethasone & remdesivir.  Discharge to: Home or Self Care.
I had a swelling and my arm got hot at injection site ( small allergic reaction- a red line). It felt like when I used to get allergy shots for cats.  It got better by that Wednesday  (01/13/2021). I had taken a Benadryl that date for my itchy nose and dry eyes (I thought it was seasonal allergies.) Today one week and a day after injection my arm swelled up again and is hot . A large red bump appears at the injection site.   Again it feels like when I used to get my allergy shots.  My  throat feels itchy as well, breathing is normal.
This spontaneous report as received from a registered pharmacist refers to a 25 years old female nurse. The patient was vaccinated with a 0.5 ml dose of (Merck) VARIVAX (lot # reported as H016715; expiration date: 07-SEP-2014) intradermally on 12-JAN-2013. No other co-suspects were reported. No concomitant medications were reported. The nurse reported that the skin at her insertion site had fluid-filled blister, like the solution did not go in deep enough, The nurse clarified that the blister did not look like a varicella-like rash, but more like a single collection of fluid immediately beneath the surface of her skin. The nurse who received the dose of (Merck) VARIVAX told the pharmacist that it looked like the dose was injected intradermally. When the nurse took off the bandage that was covering her injection site, she reported to the pharmacist that her skin ripped off. At the time of the report, the patient had not recovered. This is one of several reports received from the same source. Additional information has been requested.
Received an expired dose of the Moderna COVID-19 Vaccine as a booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received an expired dose of the Moderna COVID-19 Vaccine as a booster dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A, 042L20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired dose of the Moderna COVID-19 Vaccine as a booster dose). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received an expired dose of the Moderna COVID-19 Vaccine as a booster dose) had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
A non-serious spontaneous report of inadvertent administration of expired H1N1 received from a registered nurse/health professional concerning a five-year-old female out of eight patients. Neither relevant medical history nor concomitant medications have been reported for this patient. The vaccine was expired on 15-Jan-2010. On 25-Jan-2010, the patient received the expired H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments were not applicable, and the event was considered resolved.
In 1990 pt recvd a series of Engerix-B (exact dates & doses unspecified) & did not convert to a pos antibody until 6th dose;
Administer expired vaccine to patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration.) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.  On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration.) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses.  The vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to MOD-2022-581986 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live follow up received included non significant information of secondary reporter was added.
Patient went home and had no difficulty however 1 week after getting shots hard red area appeared where injection was given and patient is now having fever as well. At this time knot still appears.
Pt received Pfizer-COVID vaccine (under EUA) yesterday 16 Dec 2020 at approx 1700.  She did not have any immediate problems after vaccination.  .  She woke up today feeling achy and feverish, and measured her oral temp at 1000 as 101.4 at home.  She drank fluids, but took no meds -- repeat oral temp at 1200 was 99.0.  .  Other sxms include sore arm at vaccination site with min redness but no swelling.   .  She additionally reports nasal congestion and sore throat that began 1 day prior to vaccination, that she attributed to her seasonal allergies.  No meds for allergies.  No cough or SOB.  No headache or neuro sxms.  No GI sxms.  .  She was concerned about fever and went to drive-thru COVID testing at approx 1300... results due back in 24h.  She has no known COVID contacts.  .  She works in sterile processing at NMCSD with no direct patient contact usually; She is on night shift now.  -  Fever and achy symptoms, as above, in previously healthy hospital worker, with onset approx 18h after receipt of COVID-Pfizer vaccine, dose #1.  With questionable URI-like sxms one day prior to vaccination, COVID testing was very reasonable -- and results are pending now.  If COVID test negative, this most likely represents mild-moderate systemic reaction to vaccine.  Advised no work this evening, rest at home, increase clear fluids, and take Motrin 400mg q4-6h as needed for subjective fever or achiness -- use/precautions reviewed.  Will follow-up tomorrow with this team by phone.  If vaccine reaction, expect sxms to lessen rapidly and resolve over next 1-2 days.  Indications for urgent care -- including marked worsening of sxms or new sxms -- reviewed.  She also has number for 24/7 Immunization Support.  Will file VAERS, since work missed for sxms.  Will encourage enrollment in VSAFE as well.  Advised that, if mild-moderate systemic reaction determined most likely source of sxms, dose #2 of COVID-Pfizer vaccine will still generally be recommended.  Pt expresses understanding and appreciation of all issues.
101 fever; body aches; This is a spontaneous report from a non-contactable consumer or other non hcp via Pfizer sponsored program COVAX US Support. A male patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced 101 fever, body aches on an unspecified date. Reportedly, patient received the 1st dose of the vaccine the other day and woke up this morning with 101 fever and body aches reporter wanted to know if they should to go the hospital. The patient underwent lab tests and procedures which included body temperature 101. Reportedly, no patient identifiers were provided but the reporter has firsthand knowledge of the patient and was reporting on a specific patient. There were no unaddressed medical questions referred or forwarded to medical information. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected
It felt like a common cold with a really heavy cough, and I lost my voice. I lost my voice for 4 days and had Laryngitis for a total of 2 weeks. I had appointment with the urgent care center, and they completed a chest x-ray on 02/07/2023 which showed that there was fluid around the lungs. I was prescribed prednisone and a Z-PAK of azithromycin. I was also given albuterol breathing treatments. I was also diagnosed with bronchitis. I started feeling better as far as the cold symptoms, but it caused a whirlwind with my Type 1 Diabetes causing high and low blood sugars. It took about a month to completely recover. I had to work with my endocrinologist to get my blood sugars back under control.
Pt stated initial warmth and pain and swelling at injection site along with fever and chills. now 3 days out, there is pain with movement and touch under arm, along with burning on bottom of arm and top.  Pt may seek urgent care or call md if not resolved or worsening in am
Pt was seen in our office on 2-27-04 with itchy rash on abdomen, chest, neck and face that was diagnosed as varicella. Rash consisted of less that 30 light red papulo-vesicular lesions. Rash broke out on 2-26-04. Child had exposure to varicella at school. Afebrile.
WOKE UP WITH A TREMENDOUS HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (WOKE UP WITH A TREMENDOUS HEADACHE) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021 at 10:15 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (WOKE UP WITH A TREMENDOUS HEADACHE). At the time of the report, HEADACHE (WOKE UP WITH A TREMENDOUS HEADACHE) had not resolved.            No treatment information provided.
BLURRY VISION; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: diabetes, and high blood pressure, and other pre-existing medical conditions included: Patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 17-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced blurry vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blurry vision was not reported. This report was non-serious.
Hives; Itchy Throat; Shortness of breath; Palpitations; Jitteriness; This case was reported by a nurse via call center representative and described the occurrence of hives in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number G2J53, expiry date 17th April 2023) for prophylaxis.   On 10th May 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 10th May 2022, immediately after receiving Shingrix, the patient experienced hives, itchy throat, shortness of breath, palpitations and jitteriness. The patient was treated with benadryl (nos) (Benadryl). On 10th May 2022, the outcome of the hives, itchy throat and jitteriness were recovered/resolved. On an unknown date, the outcome of the shortness of breath and palpitations were recovered/resolved.   It was unknown if the reporter considered the hives, itchy throat, shortness of breath, palpitations and jitteriness to be related to Shingrix.     Additional Information: GSK Receipt Date: 13-JUL-2022  Reporter's Comments: The reporter was a nurse from a Medical Office. The patient received first dose of Shingrix into right deltoid and right after vaccination patient developed hives, itchy throat and shortness of breath. The patient was given Benadryl then less than a day after receiving Shingrix, the patient experienced palpitations and jitteriness. The Benadryl helped with the patients' hives, but the jitteriness and the itchy throat lasted for four hours. The reporter consented to follow up.
I had been sick since this past Friday; high fever, all over body pain, constant cough and frequent sneezing, migraines , eye pain and extreme fatigue. I tested positive for Covid April 21, 2021.
Headache (day 1) ,  drowsiness, dizziness, lightheaded (4 days) increased bowl movement ( for 5 days, now taking probiotics to address it). This was not reported in any site. I may go to the doctor if i don't get better.
Imms Monday AM, no problem Tues. Wed evening entire arm (shoulder to wrist) erythematous & moderately swollen, tender with ? yellow pustule at injection site. (Routine imms procedure confirmed by medical assistant). Resolved after 48 hours more.
1st -19 hours noticed nothing  Morning following shot , worst headache ever ! - nausea and dry heaves with dizziness  - fever chilling  -stayed in bed for 33 hours straight  Tried to get up but got dizzy and sick every time  Also lower back pain with all this
Psoriasis flare-up; Bladder infection; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis flare-up) and CYSTITIS (Bladder infection) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced PSORIASIS (Psoriasis flare-up) and CYSTITIS (Bladder infection). At the time of the report, PSORIASIS (Psoriasis flare-up) and CYSTITIS (Bladder infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported. No treatment medications was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
pt was given repeat of DTaP,MMR, IPV, was given last year 8/15/2007 - filing misadministration - pt without adverse events thus far
moderna civid 19 vaccine eua  1 week later I have a localized redness, circular rash over site of vaccination.  No itching. Warm to touch.  No pain.
Tingling in arms & legs, difficulty concentrating, generalized weakness, slow movement, "burning sensation" in skin & muscles of legs, dropping objects more than usual. Friends described pt as a "zombie". Sx ended abruptly about 24 hours later.
This spontaneous report as received from a health care worker refers to a 5 year old female patient. The patients drug allergies and pertinent medical history was not reported. On 03-JUL-2013 the patient was vaccinated with M-M-R II (dose: 0.5ml) (lot # and expiry date was not reported, therapy status was not reported) subcutaneously in the left thigh. Concomitant medications were not reported. On 03-JUL-2013, the patient was vaccinated with extra dose, third dose of M-M-R II. No adverse effects were reported. The healthcare worker reported that this error occurred when they were converting their paper charts to electronic records. No product quality complaint (PQC) was reported for M-M-R II. The case is linked to case # 1407USA011741 (same reporter link. Additional information is not expected as the reporter do not want to be contacted about the report.
Information has been received from a nurse practitioner concerning a 12 month old patient who on "ten days ago" approximately 13-OCT-2006 was vaccinated with a 0.5 mL dose of Proquad. Suspect vaccination administered that day included a dose of influenza virus vaccine (unspecified). "Ten days ago" on approximately 13-OCT-2006 the patient developed a fever, rash, cold symptoms and conjunctivitis.  Subsequently, the patient recovered. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.